We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$677M
AUM Growth
+$47.9M
Cap. Flow
+$18.7M
Cap. Flow %
2.77%
Top 10 Hldgs %
30.54%
Holding
223
New
55
Increased
84
Reduced
41
Closed
38

Top Buys

Rank Stock Value
1
ROP icon
Roper Technologies
ROP
+$9.04M
2
COST icon
Costco
COST
+$8.69M
3
ED icon
Consolidated Edison
ED
+$3.04M
4
PG icon
Procter & Gamble
PG
+$2.75M
5
HRL icon
Hormel Foods
HRL
+$2.2M

Sector Composition

Rank Sector Weight
1 Technology 14.06%
2 Healthcare 12.64%
3 Consumer Staples 11.38%
4 Financials 9.76%
5 Communication Services 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLFS icon
126
BioLife Solutions
BLFS
$1.53B
$347K 0.05%
+9,642
New +$381K
EVBG
127
DELISTED
Everbridge, Inc. Common Stock
EVBG
$347K 0.05%
2,862
+598
+26% +$84.1K
MED icon
128
Medifast
MED
$109M
$345K 0.05%
1,630
-749
-31% -$179K
ENPH icon
129
Enphase Energy
ENPH
$4.96B
$344K 0.05%
+2,122
New +$381K
ALNY icon
130
Alnylam Pharmaceuticals
ALNY
$27.5B
$343K 0.05%
2,427
+308
+15% +$46.4K
CERS icon
131
Cerus
CERS
$433M
$343K 0.05%
+57,134
New +$389K
EVER icon
132
EverQuote
EVER
$892M
$342K 0.05%
+9,427
New +$402K
NVDA icon
133
NVIDIA
NVDA
$4.86T
$341K 0.05%
25,520
+1,320
+5% +$17.7K
TTD icon
134
Trade Desk
TTD
$8.48B
$341K 0.05%
5,230
-3,210
-38% -$248K
CORT icon
135
Corcept Therapeutics
CORT
$12.4B
$338K 0.05%
14,205
-3,643
-20% -$97.3K
AXON
136
Axon Enterprise
AXON
$42.5B
$337K 0.05%
+2,365
New +$369K
CRWD icon
137
CrowdStrike
CRWD
$194B
$334K 0.05%
+7,324
New +$387K
OCUL icon
138
Ocular Therapeutix
OCUL
$1.79B
$333K 0.05%
+20,281
New +$391K
GM icon
139
General Motors
GM
$80.4B
$332K 0.05%
+5,777
New +$307K
NBIX icon
140
Neurocrine Biosciences
NBIX
$16.8B
$331K 0.05%
3,405
+1,077
+46% +$113K
ZM icon
141
Zoom
ZM
$28.2B
$331K 0.05%
+1,030
New +$379K
AVLR
142
DELISTED
Avalara, Inc.
AVLR
$331K 0.05%
2,481
-198
-7% -$30.5K
BL icon
143
BlackLine
BL
$1.84B
$329K 0.05%
3,036
-513
-14% -$64K
PTON icon
144
Peloton Interactive
PTON
$2.77B
$329K 0.05%
+2,925
New +$388K
OKTA icon
145
Okta
OKTA
$24.7B
$328K 0.05%
1,490
-194
-12% -$48.8K
ACMR icon
146
ACM Research
ACMR
$5.42B
$326K 0.05%
+12,111
New +$400K
VAW icon
147
Vanguard Materials ETF
VAW
$2.95B
$326K 0.05%
1,883
+26
+1% +$4.28K
ZS icon
148
Zscaler
ZS
$24.5B
$325K 0.05%
1,896
-1,731
-48% -$344K
BLUE
149
DELISTED
bluebird bio
BLUE
$322K 0.05%
+824
New +$406K
CDNA icon
150
CareDx
CDNA
$2.26B
$322K 0.05%
4,735
-5,308
-53% -$412K

Similar funds

Spearhead Capital Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Spearhead Capital Advisors held 223 positions worth $677M, up 7.6% from $629M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q1 2021 filing shows 55 new, 84 increased, 41 reduced and 38 closed positions. Its largest new stake was Roper Technologies: 22,529 shares worth $9.09M. The largest sale was AT&T, an estimated $9.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q1 2021 buy was Roper Technologies: 22,529 shares worth $9.09M.
  • Spearhead Capital Advisors added most to Costco in Q1 2021, an estimated $8.69M increase.
  • Spearhead Capital Advisors's biggest Q1 2021 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $4.49M.
  • Spearhead Capital Advisors fully exited AT&T in Q1 2021, selling an estimated $9.9M.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $677M portfolio in Q1 2021.
  • Spearhead Capital Advisors opened 55 new positions and closed 38 in Q1 2021.
  • Spearhead Capital Advisors's portfolio value rose 7.6% quarter-over-quarter to $677M.

Based on Spearhead Capital Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.